These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1464863)

  • 1. Frequent induction of insulin autoantibodies by D-penicillamine in patients with rheumatoid arthritis.
    Vardi P; Brik R; Barzilai D; Lorber M; Scharf Y
    J Rheumatol; 1992 Oct; 19(10):1527-30. PubMed ID: 1464863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP; Homberg JC; Crouzet J; Mery C; Delrieu F; Massias P; Abuaf N
    J Rheumatol Suppl; 1981; 7():80-3. PubMed ID: 6939887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of D-penicillamine on inflammatory and immune reactions.
    Harth M; Keown PA; Orange JF
    Clin Invest Med; 1984; 7(1):45-51. PubMed ID: 6723124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are antinuclear factors a contraindication for penicillamine treatment in patients with rheumatoid arthritis? (author's transl)].
    Scherak O; Hiesberger H; Kolarz G
    Wien Klin Wochenschr; 1978 Feb; 90(3):95-6. PubMed ID: 304637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acetylcholine receptor antibody in D-penicillamine therapy].
    Kolarz G; Maida EM
    Z Rheumatol; 1986; 45(3):118-21. PubMed ID: 3751350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of D-penicillamine on the immunological indices of rheumatoid arthritis patients].
    Sheĭtanov I
    Vutr Boles; 1990; 29(4):59-64. PubMed ID: 2281661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Ann Med Interne (Paris); 1984; 135(6):420-6. PubMed ID: 6334465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of D-penicillamine and methotrexate in the treatment of rheumatoid arthritis in relation to levels of circulating rheumatoid factors of different classes].
    Zborovskiĭ AB; Sivordova LE; Derevianko LI; Zborovskaia IA; Zavodovskiĭ BV
    Ter Arkh; 1999; 71(1):60-3. PubMed ID: 10097305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
    Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK
    J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment].
    Benveniste M; Crouzet J; Homberg JC; Lessana M; Camus JP; Hewitt J
    Nouv Presse Med; 1975 Dec; 4(44):3125-8. PubMed ID: 1220709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
    Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
    J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [D-penicillamine in the treatment of rheumatoid polyarthritis. 104 cases with a 5-year follow-up].
    Valat JP; Fouquet B; Eveleigh MC; Chantreuil C; Lalot F
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):7-12. PubMed ID: 3704516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine.
    Olsen N; Ziff M; Jasin HE
    J Rheumatol; 1984 Feb; 11(1):17-21. PubMed ID: 6699830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum histidine in rheumatoid arthritis: changes induced by antirheumatic drug therapy.
    Pickup ME; Dixon JS; Lowe JR; Wright V
    J Rheumatol; 1980; 7(1):71-6. PubMed ID: 7354471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
    Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
    J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies to D-penicillamine in patients with chronic polyarthritis--diagnostic aid in undesired and insufficient drug effects?].
    Storch W; Keitel W
    Z Rheumatol; 1988; 47 Suppl 1():44-7. PubMed ID: 3213272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.